Fluoxetine News
Behavioral Therapy Adds No Benefit to SSRI Treatment in Depressed Teens
Adding weekly cognitive behavioral therapy sessions to a daily fluoxetine (Prozac) regimen was no more beneficial for depressed adolescents than medication alone, researchers here found.
Lilly ads for dog drug misleading, U.S. FDA says
Eli Lilly and Co used misleading claims to promote a version of Prozac for dogs to treat separation anxiety, neglecting to mention that dogs in a trial also got behavior training, U.S. regulators said. The Food and Drug...
Neuropharm enters final autism drug trials
NEUROPHARM, the UK biotech minnow backed by Sir Tom Hunter, the Scottish entrepreneur, and Sir Christopher Evans, the biotechnology tycoon, is launching final stage trials of what could be the world’s first drug to treat autism,...
FDA Approves Generic Versions of Xanax and Prozac
Mylan Pharmaceuticals announced FDA approval for its generic version of Eli Lily’s Prozac, while IMPAX Laboratories announced agency approval for its generic version of Pharmacia and Upjohn’s Xanax.
Mylan Announces FDA Decision on Fluoxetine Capsules
Mylan Pharmaceuticals has received final approval from the FDA for its supplemental abbreviated new drug application (ANDA) for fluoxetine capsules, 40 mg.